These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 16782216)

  • 1. Hyperuricaemia predicts poor outcome in patients with mild to moderate chronic heart failure.
    Jankowska EA; Ponikowska B; Majda J; Zymlinski R; Trzaska M; Reczuch K; Borodulin-Nadzieja L; Banasiak W; Ponikowski P
    Int J Cardiol; 2007 Feb; 115(2):151-5. PubMed ID: 16782216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Uric acid-lowering treatment with benzbromarone in patients with heart failure: a double-blind placebo-controlled crossover preliminary study.
    Ogino K; Kato M; Furuse Y; Kinugasa Y; Ishida K; Osaki S; Kinugawa T; Igawa O; Hisatome I; Shigemasa C; Anker SD; Doehner W
    Circ Heart Fail; 2010 Jan; 3(1):73-81. PubMed ID: 19933411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significance of dyslipidaemia in patients with heart failure of unexplained aetiology.
    Skwarek M; Bilińska ZT; Mazurkiewicz Ł; Grzybowski J; Kruk M; Kurjata P; Piotrowski W; Ruzyłło W
    Kardiol Pol; 2008 May; 66(5):515-22, discussion 523-4. PubMed ID: 18537059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperuricemia in acute heart failure. More than a simple spectator?
    Alimonda AL; Núñez J; Núñez E; Husser O; Sanchis J; Bodí V; Miñana G; Robles R; Mainar L; Merlos P; Darmofal H; Llácer A
    Eur J Intern Med; 2009 Jan; 20(1):74-9. PubMed ID: 19237097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Uric acid and survival in chronic heart failure: validation and application in metabolic, functional, and hemodynamic staging.
    Anker SD; Doehner W; Rauchhaus M; Sharma R; Francis D; Knosalla C; Davos CH; Cicoira M; Shamim W; Kemp M; Segal R; Osterziel KJ; Leyva F; Hetzer R; Ponikowski P; Coats AJ
    Circulation; 2003 Apr; 107(15):1991-7. PubMed ID: 12707250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prognostic value of renal dysfunction in patients with chronic heart failure: 12-month follow-up.
    Roik M; Starczewska MH; Stawicki S; Solarska-Półchłopek A; Warszawik O; Oreziak A; Kochanowski J; Kosior D; Opolski G
    Kardiol Pol; 2006 Jul; 64(7):704-11; discussion 712. PubMed ID: 16886127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic significance of serum uric acid in outpatients with chronic heart failure is complex and related to body mass index: data from the IN-CHF Registry.
    Baldasseroni S; Urso R; Maggioni AP; Orso F; Fabbri G; Marchionni N; Tavazzi L;
    Nutr Metab Cardiovasc Dis; 2012 May; 22(5):442-8. PubMed ID: 21193292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heat shock protein 70 in patients with chronic heart failure: relation to disease severity and survival.
    Genth-Zotz S; Bolger AP; Kalra PR; von Haehling S; Doehner W; Coats AJ; Volk HD; Anker SD
    Int J Cardiol; 2004 Sep; 96(3):397-401. PubMed ID: 15301893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Uric acid in cachectic and noncachectic patients with chronic heart failure: relationship to leg vascular resistance.
    Doehner W; Rauchhaus M; Florea VG; Sharma R; Bolger AP; Davos CH; Coats AJ; Anker SD
    Am Heart J; 2001 May; 141(5):792-9. PubMed ID: 11320368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contribution of renal function impairment to unexplained troponin T elevations in congestive heart failure.
    Aksoy N; Ozer O; Sari I; Sucu M; Aksoy M; Geyikli I
    Ren Fail; 2009; 31(4):272-7. PubMed ID: 19462275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impaired insulin sensitivity as an independent risk factor for mortality in patients with stable chronic heart failure.
    Doehner W; Rauchhaus M; Ponikowski P; Godsland IF; von Haehling S; Okonko DO; Leyva F; Proudler AJ; Coats AJ; Anker SD
    J Am Coll Cardiol; 2005 Sep; 46(6):1019-26. PubMed ID: 16168285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyperuricemia associated with high cardiac event rates in the elderly with chronic heart failure.
    Niizeki T; Takeishi Y; Arimoto T; Okuyama H; Nozaki N; Hirono O; Tsunoda Y; Watanabe T; Nitobe J; Miyashita T; Takahashi H; Koyama Y; Kubota I
    J Cardiol; 2006 May; 47(5):219-28. PubMed ID: 16764328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma brain natriuretic peptide predicts short-term clinical outcome in heart failure patients with restrictive filling pattern.
    Feola M; Aspromonte N; Milani L; Bobbio M; Bardellotto S; Barro S; Giovinazzo P; Noventa F; Valle R
    J Card Fail; 2008 Jun; 14(5):420-5. PubMed ID: 18514935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Are hematinic deficiencies the cause of anemia in chronic heart failure?
    Witte KK; Desilva R; Chattopadhyay S; Ghosh J; Cleland JG; Clark AL
    Am Heart J; 2004 May; 147(5):924-30. PubMed ID: 15131553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Moderate-to-severe early-onset hyperuricaemia: a prognostic marker of long-term kidney transplant outcome.
    Min SI; Yun IJ; Kang JM; Park YJ; Min SK; Ahn C; Kim SJ; Ha J
    Nephrol Dial Transplant; 2009 Aug; 24(8):2584-90. PubMed ID: 19395726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduction in circulating testosterone relates to exercise capacity in men with chronic heart failure.
    Jankowska EA; Filippatos G; Ponikowska B; Borodulin-Nadzieja L; Anker SD; Banasiak W; Poole-Wilson PA; Ponikowski P
    J Card Fail; 2009 Jun; 15(5):442-50. PubMed ID: 19477405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Erythropoietin improves anemia exercise tolerance and renal function and reduces B-type natriuretic peptide and hospitalization in patients with heart failure and anemia.
    Palazzuoli A; Silverberg D; Iovine F; Capobianco S; Giannotti G; Calabrò A; Campagna SM; Nuti R
    Am Heart J; 2006 Dec; 152(6):1096.e9-15. PubMed ID: 17161060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of high-sensitivity C-reactive protein in patients with chronic heart failure.
    Xue C; Feng Y; Wo J; Li Y
    N Z Med J; 2006 Nov; 119(1245):U2314. PubMed ID: 17146489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravenous iron reduces NT-pro-brain natriuretic peptide in anemic patients with chronic heart failure and renal insufficiency.
    Toblli JE; Lombraña A; Duarte P; Di Gennaro F
    J Am Coll Cardiol; 2007 Oct; 50(17):1657-65. PubMed ID: 17950147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of new onset anaemia on morbidity and mortality in chronic heart failure: results from COMET.
    Komajda M; Anker SD; Charlesworth A; Okonko D; Metra M; Di Lenarda A; Remme W; Moullet C; Swedberg K; Cleland JG; Poole-Wilson PA
    Eur Heart J; 2006 Jun; 27(12):1440-6. PubMed ID: 16717081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.